Stocks · Korea
054670
KOSDAQ
Daehan Nupharm
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER5.15x
PBR0.56x
EPS1,087 KRW
BPS9,971 KRW
ROE11.34%
Dividend yield1.79%
DPS100 KRW
Payout ratio9.20%
Returns and 52-week range
1W+2.75%
1M-0.71%
3M+0.90%
6M-21.68%
1Y-19.89%
YTD-15.54%
52W high7,900원
52W low5,030원
From 52W high-29.11%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 1,980억 | 276억 | 243억 | 13.9% |
| 2023 | 2,042억 | 188억 | 125억 | 9.2% |
| 2024 | 2,022억 | 187억 | 155억 | 9.2% |
| 2025 | 2,024억 | 117억 | 153억 | 5.8% |
| Quarterly | ||||
| 2024 4Q | 510억 | 38억 | 27억 | 7.4% |
| 2025 1Q | 519억 | 42억 | 26억 | 8.2% |
| 2025 2Q | 499억 | 31억 | 30억 | 6.1% |
| 2025 3Q | 489억 | 21억 | 26억 | 4.3% |
| 2025 4Q | 518억 | 23억 | 71억 | 4.5% |
| 2026 1Q | 548억 | 31억 | 30억 | 5.7% |
Company
Address: 경기도 화성시 향남읍 상신리 904-3
Recent filings
- 2026-08-28[기재정정]사업보고서 (2025.12)
- 2026-08-14반기보고서 (2026.06)
- 2026-07-07[기재정정]사업보고서 (2025.12)
- 2026-05-13분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.